Oral Presentations 38: Toxicology
Tracks
Track 6
| Thursday, July 16, 2026 |
| 9:00 AM - 10:30 AM |
Speaker
Prof Geoffrey Isbister
Calvary Mater Newcastle
Transforming snakebite management: two decades of translation from the Australian Snakebite Project
Biography
Prof Geoff Isbister is a clinical toxicologist and head of the Clinical Toxicology Research Group at the University of Newcastle, Australia. His work focuses on poisoning and envenoming, with studies that have reshaped understanding of antivenom effectiveness and improved treatment of snakebite and other envenomations.
Assoc Prof Rose Cairns
Associate Professor In Pharmacy
The University Of Sydney
Changes in pregabalin use and misuse following government interventions and media coverage
Biography
A/Prof Rose Cairns (BPharm, PhD) is an NHMRC Emerging Leadership Fellow, a Sydney Pharmacy School academic, and a Senior Poisons Specialist at the New South Wales Poisons Information Centre. Her research focuses on clinical toxicology, drug safety, pharmaceutical misuse, and self-harm, including analyses of poisons centre data and linked administrative datasets. She serves on the Therapeutic Goods Administration’s Advisory Committee for Chemicals Scheduling and is Chair of the Australian Poisoning Surveillance Initiative.
Assoc Prof Garth Maker
Murdoch University
Compliance, composition and safety of herbal weight loss supplements using 1H-NMR spectroscopy
Biography
Associate Professor Garth Maker is an award-winning research and educator in the School of Medical, Molecular & Forensic Sciences at Murdoch University in Perth. Garth’s research expertise is in the quality and safety of herbal medicines and dietary supplements, for which he received the Young Tall Poppy Science Award in 2016. Garth has led research projects investigating the composition and quality of dietary supplements including weight loss supplements and those indicated for cardiovascular and respiratory health. His specific expertise is in the chemical analysis of supplements, as well as techniques for the investigation of their biological activity.
Assoc Prof Roland Lawson
University of Limoges
Early antifungal therapy reduces diarrhea risk in mycophenolic acid-treated transplant patients
Biography
Roland Lawson, PharmD, PhD, is an Associate Professor of Pharmacology at the University of Limoges and a researcher within INSERM U1248, Pharmacology & Transplantation. His work centers on precision medicine in transplantation, with a particular focus on the complex interactions between the microbiota, the host, and immunosuppressive therapies. He aims to elucidate how these interactions shape inter-individual variability in transplant outcomes.
Dr Tayler Catherine Kent
Murdoch University
Herbal supplements disrupt central carbon metabolism and nucleotide signalling in testicular cells
Biography
Tayler is an Associate Lecturer in Human Pharmacology in the School of Medical, Molecular and Forensic Sciences at Murdoch University in Perth, WA. She coordinates the school's two pharmacology units, as well as contributing to Forensic Toxicology, Veterinary Reproduction and first-year Biomedical Science units. Tayler earned her PhD from the School of Veterinary Medicine at Murdoch, which investigated the functional and metabolic changes that occur in male reproductive cells exposed to common herbal medicines. Her current research focuses include changes to oocyte function and metabolism after exposure to endocrine disruptors, and hormone disruption and toxicity that occurs in Sertoli and Leydig cells exposed to herbal fertility supplements.
Dr Slade Matthews
The University of Sydney
Active Learning with Thompson Sampling for hERG Risk Modelling in Drug Development
Biography
Dr. Slade Matthews is a Senior Lecturer specializing in computational pharmacology and toxicology. His research focuses on predicting chemical properties and bioactivity using Python-based QSAR models and cheminformatic techniques such as molecular fingerprinting, quantum molecular calculations, clustering, and substructure analysis. He earned his PhD in 2007 on machine learning in biomedical data and has published 48 peer-reviewed papers (Scopus h-index: 18). In 2025 Slade published a state-of-the-art graph transformer-based QSAR model for Ames mutagenicity prediction. He serves on the TGA Medical and Scientific Evaluation Services Panel and the NSW Poisons Advisory Committee both since 2010. In 2024, he was elected to the ASCEPT Board and awarded Fellowship of ACTRA in 2025. Based at the University of Sydney, Slade collaborates with academic and regulatory partners to advance public safety through application of in silico toxicology and is passionate about mentoring students and interdisciplinary research bridging chemistry, biology, and data science.